LONGO, MIRIAM
 Distribuzione geografica
Continente #
AS - Asia 1.187
SA - Sud America 513
NA - Nord America 409
EU - Europa 275
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.414
Nazione #
BR - Brasile 391
US - Stati Uniti d'America 358
SG - Singapore 246
VN - Vietnam 222
HK - Hong Kong 198
CN - Cina 186
BD - Bangladesh 169
IT - Italia 114
DE - Germania 90
KR - Corea 85
AR - Argentina 38
EC - Ecuador 27
ID - Indonesia 26
MX - Messico 22
CA - Canada 18
CO - Colombia 16
FR - Francia 14
CL - Cile 12
AT - Austria 11
IN - India 11
IQ - Iraq 11
PY - Paraguay 11
RU - Federazione Russa 10
ZA - Sudafrica 10
GB - Regno Unito 7
UY - Uruguay 7
UA - Ucraina 6
UZ - Uzbekistan 6
DZ - Algeria 5
PL - Polonia 5
VE - Venezuela 5
EG - Egitto 4
MA - Marocco 4
MY - Malesia 4
PE - Perù 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
GT - Guatemala 3
TR - Turchia 3
BO - Bolivia 2
CR - Costa Rica 2
GR - Grecia 2
IE - Irlanda 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
NL - Olanda 2
NP - Nepal 2
PH - Filippine 2
PR - Porto Rico 2
SE - Svezia 2
TN - Tunisia 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BW - Botswana 1
ES - Italia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MT - Malta 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.414
Città #
Hong Kong 198
Ho Chi Minh City 96
Frankfurt am Main 85
Seoul 85
Ashburn 56
Singapore 51
Beijing 46
New York 45
Hanoi 41
São Paulo 40
San Jose 38
Chicago 31
Rio de Janeiro 16
Haiphong 15
Los Angeles 13
Rome 13
Mexico City 12
Guayaquil 11
Belo Horizonte 10
Brasília 10
Curitiba 10
Milan 10
Naples 10
Buffalo 9
Quito 9
Salvador 9
Santa Clara 8
Hillsboro 7
Thái Bình 7
Biên Hòa 6
Campinas 6
Da Nang 6
Jakarta 6
Montevideo 6
Sorocaba 6
Tashkent 6
Toronto 6
Bologna 5
Council Bluffs 5
Dallas 5
Houston 5
Nuremberg 5
Asunción 4
Can Tho 4
Concepción 4
Guarulhos 4
Ha Long 4
Joinville 4
Kuala Lumpur 4
Macaé 4
Medellín 4
Paris 4
Pouso Alegre 4
Santiago 4
Santo André 4
Thái Nguyên 4
Vienna 4
Warsaw 4
Anápolis 3
Araraquara 3
Baghdad 3
Bexley 3
Boardman 3
Bogotá 3
Brescia 3
Camaçari 3
Cape Town 3
Charlotte 3
Chongqing 3
Corato 3
Florence 3
Fortaleza 3
Guatemala City 3
Hải Dương 3
Jacksonville 3
Kochi 3
Limeira 3
Manassas 3
Ninh Bình 3
Pasadena 3
Philadelphia 3
Phủ Lý 3
Piracicaba 3
Porto Alegre 3
Santa Rita 3
São Bernardo do Campo 3
Sóc Trăng 3
The Dalles 3
Americana 2
Araxá 2
Athens 2
Atlanta 2
Bagnatica 2
Baixo Guandu 2
Bari 2
Barra do Garças 2
Barueri 2
Brooklyn 2
Burlington 2
Bắc Giang 2
Totale 1.242
Nome #
Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS 65
Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules 60
Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial 58
Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis 50
Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome 47
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs 47
Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial 46
Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials 45
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes 43
Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes 42
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 42
Change in circulating levels of endothelial progenitor cells and sexual function in women with type 1 diabetes 41
GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials 41
Sleep quality and glucose control in adults with type 1 diabetes during the seasonal daylight saving time shifts 40
Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials With Meta-Analysis 40
Effects of Mediterranean diet on semen parameters in healthy young adults: a randomized controlled trial 39
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 38
Patient-specific factors, patient preference, and nodule size as implications in the initial surgery of high risk indeterminate thyroid nodules 38
Mediterranean diet in type 2 diabetes: An updated overview of pharmacological activities of cardiometabolic and reproductive outcomes 38
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues 38
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression 37
Telemedicine for type 2 diabetes during COVID-19 pandemic: experience from a tertiary diabetes center 37
Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta-analysis with meta-regression 36
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs 36
Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials 36
Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study 36
Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes 35
Exploring the performance of ultrasound risk stratification systems in thyroid nodules of pediatric patients 34
Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center 34
When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes 34
Unilateral Graves' disease: a case report with concomitant thyroid cancer and systematic review of literature 33
Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies 33
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice 33
Remission of Pituitary Autoimmunity Induced by Gluten-Free Diet in Patients With Celiac Disease 32
BEYOND 4 years: simplification of complex insulin regimens with a fixed-ratio combination of basal insulin plus a GLP-1 receptor agonist or basal insulin plus an SGLT-2 inhibitor 32
Mediterranean Diet and COVID-19: Hypothesizing Potential Benefits in People With Diabetes 32
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs 31
Feasibility of simplification from a basal-bolus insulin regimen to a fixed-ratio formulation of basal insulin plus a glp-1ra or to basal insulin plus an SGLT2 inhibitor: BEYOND, a randomized, pragmatic trial 31
Applications for social security benefits related to diabetes in the working age in Italy between 2009 and 2019: a nationwide retrospective cohort study 31
Neuroimmunoendocrinology of SARS-CoV 2 Infection 31
Female Sexual Function in Young Women With Type 1 Diabetes and Additional Autoimmune Diseases 31
The effects of GIP, GLP-1 and GLP-2 on markers of bone turnover: a review of the gut-bone axis 31
Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy 30
Fixed-ratio combination of GLP-1 receptor agonist and basal insulin: simplifying type 2 diabetes treatment 30
Assessment of Neuroendocrine Changes and Hypothalamo-Pituitary Autoimmunity in Patients with COVID-19 30
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies 30
Prevalence and Management of Complications of Percutaneous Ethanol Injection for Cystic Thyroid Nodules: A Systematic Review of Literature and Meta-analysis 30
Varicocele: An Endocrinological Perspective 29
Renal and metabolic effects of SGLT-2i and DPP-4i according to basal estimated glomerular filtration rate: Analysis from GIOIA, an observational prospective study 29
The role of autoimmunity in pituitary dysfunction due to traumatic brain injury 29
EMPATHY: A New Tool for Identifying the Most Suitable Thyroxine Formulation in Hypothyroid Patients 28
New insights into vitamin D regulation: is there a role for alkaline phosphatase? 28
Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy 27
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off 27
Simplification of complex insulin therapy: a story of dogma and therapeutic resignation 27
Sexual dysfunctions in young women with type 1 diabetes and high glucose variability: findings from the METRO study 26
Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes 25
Impact of Pituitary Autoimmunity and Genetic Disorders on Growth Hormone Deficiency in Children and Adults 25
Long-term diabetic complications as predictors of foot ulcers healing failure: A retrospective study in a tertiary-care center 24
Are gliflozins the new statins for diabetes? 23
Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials. Endocrine. 23
Glucose monitoring in diabetes: A suggested algorithm to choice the best treatment option 23
The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials 23
Free and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists versus basal insulin intensification in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials 23
Metabolic effectiveness of gliflozins and gliptins in the routine clinical practice of patients with type 2 diabetes: preliminary results from GIOIA, a prospective multicentre study 22
Reply to the letter to the editor by Mungmunpuntipantip et al 21
Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes. 21
Semen quality and metabolic profile in people with type 1 diabetes with and without erectile dysfunction: a cross-sectional study. 21
Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak? 21
Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring 21
Response to Letter to the Editor From Maino et al: "Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-Analysis" 16
Real-world safety comparison of liraglutide and semaglutide in weight management: Insights from European pharmacovigilance data 16
Real-world glycemic outcomes of a tubeless automated insulin delivery system: a single-center observational study in Italy 13
Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index 13
Ethanol ablation of cystic thyroid nodules: institutional experience with one year follow-up 12
Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts 11
Islet Autoantibodies in Adult With Pituitary and Ovarian Autoimmunity: Implications for Type 1 Diabetes Screening 9
Quality of Life After Ethanol Ablation of Thyroid Nodules: A 1-Year Follow-Up Study 9
Ablation of cystic thyroid nodules with or without the injection of ethanol prior to aspiration: a one-year follow-up study 7
Impact of Semaglutide on Limb Events: A Meta-Analysis of Randomized Controlled Trials 7
Angiogenic T cells and cognitive function in older adults with type 2 diabetes treated with GLP-1 receptor agonists 7
Smart insulin pen after pancreatectomy: a successful strategy for managing type 3c diabetes 7
Do Levothyroxine Adjustments During Pregnancy Differ Between Users of Tablet and Nontablet Formulation? A Real-World Study 6
GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies 5
The therapeutic efficacy of continuous glucose monitoring in diabetes: an updated meta-analysis with meta-regression 5
Immune checkpoint inhibitors and metabolic events: results from a European safety analysis 5
Sodium‐glucose co‐transporter‐2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis 3
The Glycemia Risk Index (GRI) as a Biomarker for Subclinical Endothelial Dysfunction in Type 1 Diabetes: A Cross-Sectional Study 3
Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance database 2
Totale 2.506
Categoria #
all - tutte 15.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025315 0 0 0 0 2 2 1 1 2 100 144 63
2025/20262.191 132 63 350 511 158 24 29 116 143 200 246 219
Totale 2.506